Qiming U.S. Healthcare GP II LLC 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-28 4:03 pm Purchase |
2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS |
Qiming U.S. Healthcare GP II LLC | 298,340 7.200% |
298,340 (New Position) |
Filing |